NAGE 8-K 2026-06-29

Niagen Bioscience, Inc. (NAGE) 8-K dated 2026-06-29 — accession 0001386570-26-000035. This URL is the filing, not the NAGE hub.

Niagen Bioscience, Inc. (NAGE) is a biotechnology company listed on US.

Niagen Bioscience, Inc. filed a 8-K on 2026-06-29. Accession 0001386570-26-000035.

Cached items: 5.07. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported NAGE revenue for 2025-12-31 was $129.4M. Net income was $17.4M. Revenue was up 29.9% from 2024-12-31 to 2025-12-31. NAGE currently screens at market cap $836.5M.

Not investment advice. The NAGE SEC hub lists recent forms. The stock page is the research view.